Drug · DIN 02502666
IDACIO
SINGLE-USE VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since May 29, 2024.
- Drug Identification Number (DIN)
- 02502666
- Company (DIN owner)
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Adalimumab L04AB04
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ADALIMUMAB | 40 MG | 0.8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 30, 2020: NOC 24521New Drug Submission (NDS)
Other DINs named IDACIO
- DIN 02502674 · Marketed
- DIN 02502682 · Marketed